Literature DB >> 22271344

Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6.

Daniela L Krause1, Jenny K Wagner, Agnes Wildenauer, Judith Matz, Elif Weidinger, Michael Riedel, Michael Obermeier, Rudolf Gruber, Markus Schwarz, Norbert Müller.   

Abstract

Several studies have shown an involvement of the immune system, in particular the monocytic system, in the pathophysiology of schizophrenia. Beside others, the monocyte-derived cytokines TNF-α, IL-6 and IL-10 were found to be affected. Since cytokines are secreted by several different cell types, the cellular source is only clear if intracellular levels are measured. Thus, in order to study the monocytic system in schizophrenia, the intracellular levels of TNF-α, IL-6 and IL-10 were determined. The intracellular concentration of TNF-α, IL-6 and IL-10 in CD33 positive monocytes was evaluated in schizophrenic patients and controls with monoclonal antibodies against these cytokines. In addition, in vitro stimulation with lipopolysaccharide (LPS) or poly I/C, which mimic a bacterial and viral infection, was performed before immunocytochemistry. At baseline, monocytic IL-6 levels were significantly lower in schizophrenic patients than in controls. After stimulation with LPS, compared with baseline, monocytic intracellular IL-6 production tended to increase more in schizophrenic patients. The present results provide further support for the hypothesis of an involvement of a dysfunction of the monocytic system in the pathophysiology of schizophrenia and indicate that especially the pro-inflammatory immune response seems to be impaired.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271344     DOI: 10.1007/s00406-012-0290-2

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  33 in total

Review 1.  Cytokines and the brain: implications for clinical psychiatry.

Authors:  Z Kronfol; D G Remick
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

2.  Antibodies to infectious agents in individuals with recent onset schizophrenia.

Authors:  F Markus Leweke; Christoph W Gerth; Dagmar Koethe; Joachim Klosterkötter; Inna Ruslanova; Bogdana Krivogorsky; E Fuller Torrey; Robert H Yolken
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-02       Impact factor: 5.270

3.  Prenatal infection as a risk factor for schizophrenia.

Authors:  Alan S Brown
Journal:  Schizophr Bull       Date:  2006-02-09       Impact factor: 9.306

Review 4.  Are some cases of psychosis caused by microbial agents? A review of the evidence.

Authors:  R H Yolken; E F Torrey
Journal:  Mol Psychiatry       Date:  2008-02-12       Impact factor: 15.992

5.  Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses.

Authors:  Matthew G Frank; Michael V Baratta; David B Sprunger; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2006-05-02       Impact factor: 7.217

6.  Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease.

Authors:  J W Chang; P D Coleman; M K O'Banion
Journal:  Neurobiol Aging       Date:  1996 Sep-Oct       Impact factor: 4.673

Review 7.  Sensitization phenomena in psychiatric illness: lessons from the kindling model.

Authors:  J E Kraus
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

8.  Triple immunofluorescence flow cytometry, using whole blood, of CD4+ and CD8+ lymphocytes expressing CD45RO and CD45RA.

Authors:  R Gruber; C Reiter; G Riethmüller
Journal:  J Immunol Methods       Date:  1993-08-09       Impact factor: 2.303

9.  Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.

Authors:  Stéphane Potvin; Emmanuel Stip; Amir A Sepehry; Alain Gendron; Ramatoulaye Bah; Edouard Kouassi
Journal:  Biol Psychiatry       Date:  2007-11-19       Impact factor: 13.382

10.  Association between intracellular infectious agents and Tourette's syndrome.

Authors:  Daniela Krause; Judith Matz; Elif Weidinger; Jenny Wagner; Agnes Wildenauer; Michael Obermeier; Michael Riedel; Norbert Müller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11-05       Impact factor: 5.270

View more
  5 in total

1.  Impaired monocyte activation in schizophrenia: ultrastructural abnormalities and increased IL-1β production.

Authors:  Natalya A Uranova; P D Bonartsev; L V Androsova; V I Rakhmanova; V G Kaleda
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-17       Impact factor: 5.270

2.  Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Bintou Gassama; Dale Sebastian; Peter Buckley; Andrew Mellor
Journal:  Biol Psychiatry       Date:  2012-10-11       Impact factor: 13.382

Review 3.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

4.  Biomarkers and neurobiology of schizophrenia.

Authors:  Peter Falkai; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08       Impact factor: 5.270

5.  Old and New Biomarkers for Infection, Inflammation, and Autoimmunity in Treatment-Resistant Affective and Schizophrenic Spectrum Disorders.

Authors:  Christian Scheiber; Tanja Schulz; Julian M Schneider; Karl Bechter; E Marion Schneider
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.